MELEXIS NV (MELE.BR) Fundamental Analysis & Valuation

EBR:MELE • BE0165385973

Current stock price

58.2 EUR
+1.25 (+2.19%)
Last:

This MELE.BR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. MELE.BR Profitability Analysis

1.1 Basic Checks

  • MELE had positive earnings in the past year.
  • In the past year MELE had a positive cash flow from operations.
  • Each year in the past 5 years MELE has been profitable.
  • Each year in the past 5 years MELE had a positive operating cash flow.
MELE.BR Yearly Net Income VS EBIT VS OCF VS FCFMELE.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M

1.2 Ratios

  • With a decent Return On Assets value of 12.46%, MELE is doing good in the industry, outperforming 70.42% of the companies in the same industry.
  • MELE has a Return On Equity of 23.22%. This is in the better half of the industry: MELE outperforms 71.83% of its industry peers.
  • MELE has a Return On Invested Capital of 13.97%. This is in the better half of the industry: MELE outperforms 69.01% of its industry peers.
Industry RankSector Rank
ROA 12.46%
ROE 23.22%
ROIC 13.97%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MELE.BR Yearly ROA, ROE, ROICMELE.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

1.3 Margins

  • With a Profit Margin value of 13.40%, MELE perfoms like the industry average, outperforming 52.11% of the companies in the same industry.
  • MELE's Profit Margin has been stable in the last couple of years.
  • MELE's Operating Margin of 15.96% is in line compared to the rest of the industry. MELE outperforms 49.30% of its industry peers.
  • In the last couple of years the Operating Margin of MELE has remained more or less at the same level.
  • MELE has a worse Gross Margin (38.59%) than 76.06% of its industry peers.
  • In the last couple of years the Gross Margin of MELE has remained more or less at the same level.
Industry RankSector Rank
OM 15.96%
PM (TTM) 13.4%
GM 38.59%
OM growth 3Y-16.81%
OM growth 5Y1.3%
PM growth 3Y-17.17%
PM growth 5Y-0.38%
GM growth 3Y-3.44%
GM growth 5Y1.26%
MELE.BR Yearly Profit, Operating, Gross MarginsMELE.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

6

2. MELE.BR Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), MELE is creating some value.
  • There is no outstanding debt for MELE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MELE.BR Yearly Shares OutstandingMELE.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
MELE.BR Yearly Total Debt VS Total AssetsMELE.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • An Altman-Z score of 6.18 indicates that MELE is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of MELE (6.18) is comparable to the rest of the industry.
  • The Debt to FCF ratio of MELE is 3.32, which is a good value as it means it would take MELE, 3.32 years of fcf income to pay off all of its debts.
  • MELE has a Debt to FCF ratio (3.32) which is comparable to the rest of the industry.
  • MELE has a Debt/Equity ratio of 0.63. This is a neutral value indicating MELE is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.63, MELE is not doing good in the industry: 80.28% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 3.32
Altman-Z 6.18
ROIC/WACC1.18
WACC11.88%
MELE.BR Yearly LT Debt VS Equity VS FCFMELE.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M

2.3 Liquidity

  • MELE has a Current Ratio of 5.46. This indicates that MELE is financially healthy and has no problem in meeting its short term obligations.
  • MELE has a Current ratio of 5.46. This is amongst the best in the industry. MELE outperforms 88.73% of its industry peers.
  • A Quick Ratio of 2.63 indicates that MELE has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 2.63, MELE belongs to the top of the industry, outperforming 80.28% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.46
Quick Ratio 2.63
MELE.BR Yearly Current Assets VS Current LiabilitesMELE.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

4

3. MELE.BR Growth Analysis

3.1 Past

  • MELE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -34.04%.
  • MELE shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.29% yearly.
  • Looking at the last year, MELE shows a decrease in Revenue. The Revenue has decreased by -9.99% in the last year.
  • Measured over the past years, MELE shows a quite strong growth in Revenue. The Revenue has been growing by 10.59% on average per year.
EPS 1Y (TTM)-34.04%
EPS 3Y-17%
EPS 5Y10.29%
EPS Q2Q%24.44%
Revenue 1Y (TTM)-9.99%
Revenue growth 3Y0.14%
Revenue growth 5Y10.59%
Sales Q2Q%8.66%

3.2 Future

  • MELE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.02% yearly.
  • MELE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.71% yearly.
EPS Next Y8%
EPS Next 2Y17.16%
EPS Next 3Y17.33%
EPS Next 5Y14.02%
Revenue Next Year0.9%
Revenue Next 2Y4.94%
Revenue Next 3Y6.08%
Revenue Next 5Y6.71%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MELE.BR Yearly Revenue VS EstimatesMELE.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B
MELE.BR Yearly EPS VS EstimatesMELE.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8

4

4. MELE.BR Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 20.86, MELE is valued on the expensive side.
  • MELE's Price/Earnings ratio is rather cheap when compared to the industry. MELE is cheaper than 80.28% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.34. MELE is valued slightly cheaper when compared to this.
  • With a Price/Forward Earnings ratio of 19.32, MELE is valued on the expensive side.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of MELE indicates a somewhat cheap valuation: MELE is cheaper than 78.87% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 38.18. MELE is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 20.86
Fwd PE 19.32
MELE.BR Price Earnings VS Forward Price EarningsMELE.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • 70.42% of the companies in the same industry are more expensive than MELE, based on the Enterprise Value to EBITDA ratio.
  • 78.87% of the companies in the same industry are more expensive than MELE, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 24.25
EV/EBITDA 13.82
MELE.BR Per share dataMELE.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • MELE's earnings are expected to grow with 17.33% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.61
PEG (5Y)2.03
EPS Next 2Y17.16%
EPS Next 3Y17.33%

7

5. MELE.BR Dividend Analysis

5.1 Amount

  • MELE has a Yearly Dividend Yield of 4.68%, which is a nice return.
  • Compared to an average industry Dividend Yield of 0.65, MELE pays a better dividend. On top of this MELE pays more dividend than 98.59% of the companies listed in the same industry.
  • MELE's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 4.68%

5.2 History

  • The dividend of MELE is nicely growing with an annual growth rate of 10.98%!
Dividend Growth(5Y)10.98%
Div Incr Years0
Div Non Decr Years7
MELE.BR Yearly Dividends per shareMELE.BR Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

5.3 Sustainability

  • 131.42% of the earnings are spent on dividend by MELE. This is not a sustainable payout ratio.
  • MELE's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP131.42%
EPS Next 2Y17.16%
EPS Next 3Y17.33%
MELE.BR Yearly Income VS Free CF VS DividendMELE.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M
MELE.BR Dividend Payout.MELE.BR Dividend Payout, showing the Payout Ratio.MELE.BR Dividend Payout.PayoutRetained Earnings

MELE.BR Fundamentals: All Metrics, Ratios and Statistics

MELEXIS NV

EBR:MELE (4/14/2026, 7:00:00 PM)

58.2

+1.25 (+2.19%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-04
Earnings (Next)04-29
Inst Owners17.67%
Inst Owner ChangeN/A
Ins Owners25%
Ins Owner ChangeN/A
Market Cap2.35B
Revenue(TTM)839.62M
Net Income(TTM)112.51M
Analysts76
Price Target63.91 (9.81%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.68%
Yearly Dividend3.7
Dividend Growth(5Y)10.98%
DP131.42%
Div Incr Years0
Div Non Decr Years7
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-13.76%
Min EPS beat(2)-20.2%
Max EPS beat(2)-7.32%
EPS beat(4)1
Avg EPS beat(4)3.1%
Min EPS beat(4)-20.2%
Max EPS beat(4)42.38%
EPS beat(8)2
Avg EPS beat(8)-3.06%
EPS beat(12)5
Avg EPS beat(12)-2.06%
EPS beat(16)8
Avg EPS beat(16)0.6%
Revenue beat(2)0
Avg Revenue beat(2)-2.39%
Min Revenue beat(2)-2.86%
Max Revenue beat(2)-1.91%
Revenue beat(4)1
Avg Revenue beat(4)-0.84%
Min Revenue beat(4)-2.86%
Max Revenue beat(4)3.28%
Revenue beat(8)1
Avg Revenue beat(8)-1.88%
Revenue beat(12)2
Avg Revenue beat(12)-1.62%
Revenue beat(16)5
Avg Revenue beat(16)-1.08%
PT rev (1m)-0.61%
PT rev (3m)-11.47%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.24%
EPS NY rev (1m)-1.16%
EPS NY rev (3m)-15.22%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.93%
Revenue NY rev (1m)-0.62%
Revenue NY rev (3m)-7.32%
Valuation
Industry RankSector Rank
PE 20.86
Fwd PE 19.32
P/S 2.8
P/FCF 24.25
P/OCF 18.62
P/B 4.85
P/tB 4.86
EV/EBITDA 13.82
EPS(TTM)2.79
EY4.79%
EPS(NY)3.01
Fwd EY5.18%
FCF(TTM)2.4
FCFY4.12%
OCF(TTM)3.13
OCFY5.37%
SpS20.78
BVpS11.99
TBVpS11.96
PEG (NY)2.61
PEG (5Y)2.03
Graham Number27.44
Profitability
Industry RankSector Rank
ROA 12.46%
ROE 23.22%
ROCE 16.8%
ROIC 13.97%
ROICexc 14.61%
ROICexgc 14.63%
OM 15.96%
PM (TTM) 13.4%
GM 38.59%
FCFM 11.55%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-16.81%
OM growth 5Y1.3%
PM growth 3Y-17.17%
PM growth 5Y-0.38%
GM growth 3Y-3.44%
GM growth 5Y1.26%
F-Score5
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 3.32
Debt/EBITDA 1.64
Cap/Depr 55.05%
Cap/Sales 3.5%
Interest Coverage 14.46
Cash Conversion 67.44%
Profit Quality 86.17%
Current Ratio 5.46
Quick Ratio 2.63
Altman-Z 6.18
F-Score5
WACC11.88%
ROIC/WACC1.18
Cap/Depr(3y)125.38%
Cap/Depr(5y)110.34%
Cap/Sales(3y)6.34%
Cap/Sales(5y)5.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-34.04%
EPS 3Y-17%
EPS 5Y10.29%
EPS Q2Q%24.44%
EPS Next Y8%
EPS Next 2Y17.16%
EPS Next 3Y17.33%
EPS Next 5Y14.02%
Revenue 1Y (TTM)-9.99%
Revenue growth 3Y0.14%
Revenue growth 5Y10.59%
Sales Q2Q%8.66%
Revenue Next Year0.9%
Revenue Next 2Y4.94%
Revenue Next 3Y6.08%
Revenue Next 5Y6.71%
EBIT growth 1Y-39.08%
EBIT growth 3Y-16.7%
EBIT growth 5Y12.03%
EBIT Next Year45.42%
EBIT Next 3Y25.78%
EBIT Next 5Y18.48%
FCF growth 1Y-22.5%
FCF growth 3Y-13.14%
FCF growth 5Y6.45%
OCF growth 1Y-29.12%
OCF growth 3Y-12.39%
OCF growth 5Y5.69%

MELEXIS NV / MELE.BR Fundamental Analysis FAQ

What is the ChartMill fundamental rating of MELEXIS NV (MELE.BR) stock?

ChartMill assigns a fundamental rating of 5 / 10 to MELE.BR.


What is the valuation status of MELEXIS NV (MELE.BR) stock?

ChartMill assigns a valuation rating of 4 / 10 to MELEXIS NV (MELE.BR). This can be considered as Fairly Valued.


Can you provide the profitability details for MELEXIS NV?

MELEXIS NV (MELE.BR) has a profitability rating of 5 / 10.


What are the PE and PB ratios of MELEXIS NV (MELE.BR) stock?

The Price/Earnings (PE) ratio for MELEXIS NV (MELE.BR) is 20.86 and the Price/Book (PB) ratio is 4.85.


Is the dividend of MELEXIS NV sustainable?

The dividend rating of MELEXIS NV (MELE.BR) is 7 / 10 and the dividend payout ratio is 131.42%.